This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Addison Disease Testing Market

Explore FMI’s in-depth coverage on the Addison disease testing market, complete with incisive analysis of key industry trends, segments and regions.

Addison Disease Testing Market by Testing Type, End User & Region - Forecast 2022 - 2032

Addison Disease Testing Market Outlook (2022-2032)

[302 Pages Report] The global Addison disease testing market is expected to garner US$ 241.8 Million in 2022 and is likely to exhibit a CAGR of 5.3% to be valued at US$ 426.8 Million in 2032. The introduction of the emergency card and growing healthcare spending are bolstering the demand for Addison Disease Testing across the globe, states Future Market Insights report.

“Due to its mutable appearance, a high index of suspicion for Addison disease is essential when assessing a conglomeration of non-specific symptoms. Thereby, early testing is necessary to provide better medical assistance to the patients.”

Data Points

Key Statistics

Global Addison Disease Testing Market CAGR (2022-2032)

5.3%

Global Addison Disease Testing Market (2022)

US$ 241.8 Million

Global Addison Disease Testing Market (2032)

US$ 426.8 Million

Global Addison Disease Testing Market Attraction

The rising number of private diagnostic centers, the mounting awareness regarding Addison disease, and initiatives taken by healthcare organizations and the government is likely to augment the demand for Addison disease testing throughout the forecast period.

Addison’s disease also called chronic adrenocortical insufficiency occurs because of the damaging of the adrenal cortex resulting in insufficient production of the hormone cortisol & aldosterone. The disease is characterized by symptoms such as weight loss, decreased appetite, extreme fatigue, hyperpigmentation, low blood pressure, and several others.

Not treating the disease for a long-time result in an Addisonian crisis which is a life-threatening medical emergency. People suffering from anticoagulants, cancer, chronic infections, and tuberculosis are more likely to be affected by the disease. Doctors look for the medical history and do a physical examination as well as various laboratory tests for diagnosing the disease.

Idiopathic autoimmune Addison disease is found to be more common in children, females, and people within the age group of 30-50 years. Delaying in diagnosis and treatment of the disease may lead to high chances of morbidity and mortality. Addison disease is considered a rare disease in many parts of the world. The testing service includes a number of the laboratory as well as imaging studies.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the factors propelling the Global Addison Disease Testing Market?

The increasing rate of adrenal insufficiency is also increasing cases of Addison disease and thus increasing the testing service market. Increasing government initiatives in improving the healthcare sector and providing access to a large population with diagnostic service facilities increases the market. Furthermore, an increase in the number of private diagnostic service providers, will in turn increase the overall testing service market.

Besides, enhanced healthcare infrastructure in emerging countries and the swelling number of regulatory endorsements for immunoassay practices further drive the demand for Addison disease testing across the globe.

What are the Factors Hampering the Global Addison Disease Testing Market?

Limitation to accessing healthcare facilities in various parts of the globe curbs the market to grow. The ignorance of symptoms and lack of healthcare facilities for every segment of society also restricts the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Emerging as an Opportunistic Addison Disease Testing Market?

North America is owing to high concerns for human health and growing awareness with the benefit of government initiative in this direction thus represents the largest market for the testing services. North America is expected to hold a 29% share in the Addison Disease Testing Market in 2022, states Future Market Insights report.

Nearly 1 in 100,000 people in the United States is affected by Addison’s disease. The global prevalence is projected to be between 40 and 60 people per million of the general population. The prominent reason behind this is that cases of Addison’s disease may go undiagnosed, it is challenging to determine its accurate frequency in the general population. Thereby, several governments are running awareness programs and organizing medical camps to increase the testing percentage in the region.

For instance, In May 2020, the Addison self-help group celebrated the International Addison’s day to improve the treatment of people with Addison's Disease and Adrenal Insufficiency and create awareness by starting several initiatives on social media. This group facilitates the sharing of emergency injection kit and encourage people to keep their kit with them at all times and normalize this potentially scary situation.

Besides, the increment in the Healthcare budget in the past two to three decades in the countries like U.S & Canada has played an imperative role in the amplified testing and avail better medical facilities in the region. According to the Journal of American Medical Association (JAMA), healthcare expenditure in the U.S. upsurged near a trillion dollars in the past two decades. The association revealed that healthcare expenditure in the U.S. during 2020 was around $3.8 trillion, i. e, $11,000 per person. These expenditures are likely to be $6 trillion—nearly $17,000 per person by 2032.

Why is the demand for Addison Disease Testing Burgeoning in Europe? 

Europe is likely to capture nearly 27% share in 2022 and is the second-largest region in terms of market contribution. This market growth is attributed to the higher prevalence rate and good diagnostic services vailable in the region. Several governments are running programs to form a strong healthcare platform for curing chronic diseases like Addison’s disease which impact millions.

For instance, In October 2014, during a conference of the European Council of Affiliated Societies (ECAS), the active countries launched a uniform "emergency card" for patients affected by adrenal insufficiency. This card was made available for patients across the Europe region, thereby the demand for Addison disease testing is likely to surge in the coming years.

In 2022, the Addison’s Disease Self-Help Group (ADSHG) announced its sponsorship of 3 CoMICs team members to the European Society of Endocrinology (ESE) Conference 2022. Such initiatives are likely to generate more awareness of Addison’s disease testing, especially in the Europe region.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

The Start-Up Ecosystem- How Key Disruptors are Calling the Shots?

While the Addison disease treatment landscape appears quite niche, a host of start-ups have capitalized on this opportunity to introduce novel treatment, diagnostic and therapeutic approaches across the world. Some notable start-ups offering Addison disease treatment are as follows:

  • Addison Care
  • SameDay Security
  • Vitruvian BioMedical
  • Addison Care offers a virtual health assistant for managing weight or chronic illness. The company offers smart devices weight scale, non-contact thermometer, glucose meter, blood pressure cuff or pulse oximeter. For tracking the health data. The platform provides reminders to measure the vitals, tracks the data from the devices and uses AI to analyse the health data.
  • In January 2019, SameDay Security secured a $32 million in a Series D fundraising round, which will help in the development and rollout of “Addison” — a virtual caregiver that could be deployed in senior living to extend length of stay.

Who are the Key Players in the Global Addison Disease Testing Market?

Some of the players in the Addison Disease Testing service market involve Diagnostic Laboratory Services, Inc., Any Lab Test Now, Dr. Lal PathLabs, Laboratory Corporation of America Holdings, Sonora Quest Laboratories, Core Diagnostics Private Limited, Ayumetrix, and others.

  • In February 2020, Dr. Lal PathLabs Ltd, a Gurugram-based public diagnostics chain, spent around Rs 7.7 crore (a little over $1 million at the current exchange rate) to acquire two pathological laboratories in Maharashtra.
  • In February 2021, Genalyte, a health care diagnostics and analytics company, and Sonora Quest Laboratories, the market share leader in diagnostic laboratory testing in Arizona, announced a strategic partnership with Cigna Medicare Arizona to leverage science-based analytics to reduce costs while improving clinical outcomes for customers of Cigna Arizona's Medicare Advantage plans. 

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.3% from 2022 to 2032

Market Value in 2022

US$ 241.8 Million

Market Value in 2032

US$ 426.8 Million

Historical Period

2016-2021

Base Year for Estimation

2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Testing Type
  • End-user
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • China
  • Japan
  • South Korea
  • GCC
  • South Africa
  • Turkey

Key Companies Profiled

Customization

Available Upon Request

Key Segments Covered in the Addison Disease Testing Industry Survey

Addison Disease Testing Market by Testing Type:

  • Laboratory Addison Disease Testing
  • Comprehensive Metabolic Panel Addison Disease Testing
  • Thyroid-Stimulating Hormone (TSH) Levels Addison Disease Testing
  • ACTH Stimulation Addison Disease Testing
  • Insulin-induced Hypoglycaemia Addison Disease Test
  • Autoantibody Addison Disease Testing
  • Prolactin Addison Disease Testing
  • Imaging Studies Addison Disease Testing
  • Chest Radiograph Addison Disease Testing
  • Computed tomography (CT) Scan Addison Disease Testing

Addison Disease Testing Market by End User:

  • Addison Disease Testing in Hospitals
  • Addison Disease Testing in Clinics
  • Addison Disease Testing in Diagnostics Laboratories

Addison Disease Testing Market by Region:

  • North America Addison Disease Testing Market
  • Europe Addison Disease Testing Market
  • Asia-Pacific Addison Disease Testing Market
  • Middle East & Africa Addison Disease Testing Market
  • Latin America Addison Disease Testing Market

Frequently Asked Questions

According to Future Market Insights, the market for Addison disease testing is expected to reach US$ 241.8 Million

From 2022-2032, Addison disease testing demand is expected to surge at a CAGR of 5.3%

FMI expects the Addison disease testing market to reach US$ 426.8 Million by 2032

North America is slated to be the most promising Addison disease testing landscape, accruing a market share of 29% in 2022

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Addison Disease Testing Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Testing Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Testing Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Testing Type, 2022-2032

        5.3.1. Laboratory Testing

            5.3.1.1. Comprehensive Metabolic Panel

            5.3.1.2. Thyroid-stimulating Hormone (TSH) Levels

            5.3.1.3. ACTH Stimulation Test

            5.3.1.4. Insulin-induced Hypoglycemia Test

            5.3.1.5. Autoantibody Testing

            5.3.1.6. Prolactin Testing

        5.3.2. Imaging Studies

            5.3.2.1. Chest Radiograph

            5.3.2.2. Computed Tomography (CT) Scan

    5.4. Y-o-Y Growth Trend Analysis By Testing Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Testing Type, 2022-2032

6. Global Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Hospitals

        6.3.2. Clinics

        6.3.3. Diagnostics Laboratories

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. US

            8.2.1.2. Canada

        8.2.2. By Testing Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Testing Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Testing Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Testing Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Testing Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Testing Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Testing Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Testing Type

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Addison Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Testing Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Testing Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Addison Disease Testing Market Analysis

    13.1. US

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Testing Type

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Testing Type

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Testing Type

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Testing Type

            13.4.2.2. By End User

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Testing Type

            13.5.2.2. By End User

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Testing Type

            13.6.2.2. By End User

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Testing Type

            13.7.2.2. By End User

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Testing Type

            13.8.2.2. By End User

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Testing Type

            13.9.2.2. By End User

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Testing Type

            13.10.2.2. By End User

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Testing Type

            13.11.2.2. By End User

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Testing Type

            13.12.2.2. By End User

    13.13. GCC Countries

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Testing Type

            13.13.2.2. By End User

    13.14. South Africa

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Testing Type

            13.14.2.2. By End User

    13.15. Israel

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Testing Type

            13.15.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Testing Type

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Diagnostic Laboratory Services

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Any Lab Test Now

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Dr Lal PathLabs

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Laboratory Corporation of America Holdings

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Sonora Quest Laboratories

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Core Diagnostics Private Limited

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Ayumetrix

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Addison Disease Testing Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Addison Disease Testing Market Value (US$ Mn) Forecast by Testing Type, 2017-2032

Table 3: Global Addison Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 4: North America Addison Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Addison Disease Testing Market Value (US$ Mn) Forecast by Testing Type, 2017-2032

Table 6: North America Addison Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 7: Latin America Addison Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Addison Disease Testing Market Value (US$ Mn) Forecast by Testing Type, 2017-2032

Table 9: Latin America Addison Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Addison Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Addison Disease Testing Market Value (US$ Mn) Forecast by Testing Type, 2017-2032

Table 12: Europe Addison Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Asia Pacific Addison Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Addison Disease Testing Market Value (US$ Mn) Forecast by Testing Type, 2017-2032

Table 15: Asia Pacific Addison Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: MEA Addison Disease Testing Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Addison Disease Testing Market Value (US$ Mn) Forecast by Testing Type, 2017-2032

Table 18: MEA Addison Disease Testing Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Addison Disease Testing Market Value (US$ Mn) by Testing Type, 2022-2032

Figure 2: Global Addison Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Addison Disease Testing Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Addison Disease Testing Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Addison Disease Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Addison Disease Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Addison Disease Testing Market Value (US$ Mn) Analysis by Testing Type, 2017-2032

Figure 8: Global Addison Disease Testing Market Value Share (%) and BPS Analysis by Testing Type, 2022-2032

Figure 9: Global Addison Disease Testing Market Y-o-Y Growth (%) Projections by Testing Type, 2022-2032

Figure 10: Global Addison Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 11: Global Addison Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Addison Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Addison Disease Testing Market Attractiveness by Testing Type, 2022-2032

Figure 14: Global Addison Disease Testing Market Attractiveness by End User, 2022-2032

Figure 15: Global Addison Disease Testing Market Attractiveness by Region, 2022-2032

Figure 16: North America Addison Disease Testing Market Value (US$ Mn) by Testing Type, 2022-2032

Figure 17: North America Addison Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Addison Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Addison Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Addison Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Addison Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Addison Disease Testing Market Value (US$ Mn) Analysis by Testing Type, 2017-2032

Figure 23: North America Addison Disease Testing Market Value Share (%) and BPS Analysis by Testing Type, 2022-2032

Figure 24: North America Addison Disease Testing Market Y-o-Y Growth (%) Projections by Testing Type, 2022-2032

Figure 25: North America Addison Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 26: North America Addison Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Addison Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Addison Disease Testing Market Attractiveness by Testing Type, 2022-2032

Figure 29: North America Addison Disease Testing Market Attractiveness by End User, 2022-2032

Figure 30: North America Addison Disease Testing Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Addison Disease Testing Market Value (US$ Mn) by Testing Type, 2022-2032

Figure 32: Latin America Addison Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Addison Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Addison Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Addison Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Addison Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Addison Disease Testing Market Value (US$ Mn) Analysis by Testing Type, 2017-2032

Figure 38: Latin America Addison Disease Testing Market Value Share (%) and BPS Analysis by Testing Type, 2022-2032

Figure 39: Latin America Addison Disease Testing Market Y-o-Y Growth (%) Projections by Testing Type, 2022-2032

Figure 40: Latin America Addison Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: Latin America Addison Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Addison Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Addison Disease Testing Market Attractiveness by Testing Type, 2022-2032

Figure 44: Latin America Addison Disease Testing Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Addison Disease Testing Market Attractiveness by Country, 2022-2032

Figure 46: Europe Addison Disease Testing Market Value (US$ Mn) by Testing Type, 2022-2032

Figure 47: Europe Addison Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Addison Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Addison Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Addison Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Addison Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Addison Disease Testing Market Value (US$ Mn) Analysis by Testing Type, 2017-2032

Figure 53: Europe Addison Disease Testing Market Value Share (%) and BPS Analysis by Testing Type, 2022-2032

Figure 54: Europe Addison Disease Testing Market Y-o-Y Growth (%) Projections by Testing Type, 2022-2032

Figure 55: Europe Addison Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 56: Europe Addison Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Addison Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Addison Disease Testing Market Attractiveness by Testing Type, 2022-2032

Figure 59: Europe Addison Disease Testing Market Attractiveness by End User, 2022-2032

Figure 60: Europe Addison Disease Testing Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Addison Disease Testing Market Value (US$ Mn) by Testing Type, 2022-2032

Figure 62: Asia Pacific Addison Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Addison Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Addison Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Addison Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Addison Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Addison Disease Testing Market Value (US$ Mn) Analysis by Testing Type, 2017-2032

Figure 68: Asia Pacific Addison Disease Testing Market Value Share (%) and BPS Analysis by Testing Type, 2022-2032

Figure 69: Asia Pacific Addison Disease Testing Market Y-o-Y Growth (%) Projections by Testing Type, 2022-2032

Figure 70: Asia Pacific Addison Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 71: Asia Pacific Addison Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Addison Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Addison Disease Testing Market Attractiveness by Testing Type, 2022-2032

Figure 74: Asia Pacific Addison Disease Testing Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Addison Disease Testing Market Attractiveness by Country, 2022-2032

Figure 76: MEA Addison Disease Testing Market Value (US$ Mn) by Testing Type, 2022-2032

Figure 77: MEA Addison Disease Testing Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Addison Disease Testing Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Addison Disease Testing Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Addison Disease Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Addison Disease Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Addison Disease Testing Market Value (US$ Mn) Analysis by Testing Type, 2017-2032

Figure 83: MEA Addison Disease Testing Market Value Share (%) and BPS Analysis by Testing Type, 2022-2032

Figure 84: MEA Addison Disease Testing Market Y-o-Y Growth (%) Projections by Testing Type, 2022-2032

Figure 85: MEA Addison Disease Testing Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 86: MEA Addison Disease Testing Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Addison Disease Testing Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Addison Disease Testing Market Attractiveness by Testing Type, 2022-2032

Figure 89: MEA Addison Disease Testing Market Attractiveness by End User, 2022-2032

Figure 90: MEA Addison Disease Testing Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Legionnaire Disease Testing Market

Published : September 2019

Healthcare

Hirschsprung Disease Treatment Market

Published : September 2017

Healthcare

Addison Disease Testing Market

Published : July 2017

Healthcare

Septicemia Diagnostic Testing Market

Published : January 1970

Google translate

Addison Disease Testing Market